LGND compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

LGNDLigand Pharmaceuticals Inc

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

LGNDLigand Pharmaceuticals Inc

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

LGND

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±7.5%▼−0.45%×0.07

Q2 FY26±7.1%▼−0.80%×0.11

May 7 '26±6.2%▼−9.55%×1.55

Q1 FY26±7.8%▲+2.50%×0.32

LLY

3 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±5.1%▲+6.63%×1.29

Q2 FY26±6.2%▲+4.86%×0.79

= impliedLGND realized, solidLLY realized, hatchedOne scale, both sides: full bar = 11%× = |realized| ÷ impliedSource: market data

Q1 FY26

±5.3%

▲+9.80%

×1.85

Feb 4 '26±6.1%▲+10.33%×1.69

LGNDLigand Pharmaceuticals Inc

306.58▲+2.54%

Mkt cap$6.0BRevenue$79MQ3 FY26Revenue$268MFY25

LLYELI Lilly & Co

1,361.47▼−0.24%

Regular sessionNov 6 '26

Mkt cap$1.2TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

Regular sessionNov 6 '26

LGNDLigand Pharmaceuticals Inc

LLYELI Lilly & Co

306.58▲+2.54%

Price

1,361.47▼−0.24%

$6.0B

Mkt cap

$1.2T

Q3 FY26$79M

Revenue

$24.4BQ3 FY26

FY25$268M

Revenue

$65.2BFY25

LGND306.58▲+2.54%vsLLY1,361.47▼−0.24%Regular sessionNov 6 '26